<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38638196</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-4875</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>International journal of cardiology. Cardiovascular risk and prevention</Title><ISOAbbreviation>Int J Cardiol Cardiovasc Risk Prev</ISOAbbreviation></Journal><ArticleTitle>High prevalence of cardiac post-acute sequelae in patients recovered from Covid-19. Results from the ARCA post-COVID study.</ArticleTitle><Pagination><StartPage>200267</StartPage><MedlinePgn>200267</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">200267</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcrp.2024.200267</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Many data were published about Long-Covid prevalence, very few about the findings of new cardiac alterations (NCA) in COVID-19-recovered people. <i>ARCA-post-COVID</i> is an observational study designed to investigate the prevalence of NCA in patients recovered from Covid-19.Methods: from June 2020 to December 2022, we enrolled 502 patients with a positive nasopharyngeal swab for SARS-CoV2 and a subsequent negative one. We performed anamnesis, lab-test, and routine cardiological tests (ECG, Holter, TTE).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The median age was 56 years (IQR 44-67); women were 52.19%; in the acute phase 24.1% of patients were treated in a medical department, 7.2% in the ICU and the others at home. At the visit, 389 patients (77.49%) complained of a broad range of symptoms. We reported patients' characteristics according to the course of the disease and the persistence of symptoms. NCA were found in 138 patients (27.49%): among them 60 cases (11.95%) of pericardial effusion. Patients with NCA were older (median 60y, IQR: 47-72, vs median 56y, IQR 42-65), had a higher prevalence of smokers (27% vs 17%; p0.014), CAD (11% vs 6%; p0.048) and stroke/TIA (3.6% vs 0.3%; p0.002) and a lower prevalence of hypercholesterolemia (18% vs 30%; p0.007). The prevalence of NCA seems constant with different subtypes of the virus.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">the prevalence of NCA in patients who recovered from COVID-19 is high and constant since the beginning of the pandemic; it is predictable based on hospitalization and long-lasting symptoms (9.64%-42.52%). Patients with one of these characteristics should undergo cardiological screening.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Antoncecchi</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>UO Cardiologia PO Bari Sud, Triggiano, (BA), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoncecchi</LastName><ForeName>Ettore</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servizio di Cardiologia Centro Polispecialistico Medigea, Modugno, (Bari), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orsini</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>ARCA Toscana, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Ascenzo</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>ARCA Molise, Termoli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliviero</LastName><ForeName>Ugo</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Past dirigente medico, AUO Federico II, Napoli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savino</LastName><ForeName>Ketty</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiologia e Fisiopatologia Cardiovascolare, Universit&#xe0; e Azienda Ospedaliera di Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aloisio</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UDD Cardiologia/UTIC, Casa di Cura Villa Verde, Taranto, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casalino</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiologia ASL 3 Genovese, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lillo</LastName><ForeName>Adele</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiologia, Distretto Socio-Sanitario 10, Ospedale Fallacara, Triggiano, (BA), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiuini</LastName><ForeName>Emilia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>ASL Umbria 1, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santoro</LastName><ForeName>Giosu&#xe8;</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Associazioni Regionali Cardiologi Ambulatoriali (ARCA), Campania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manfr&#xe8;</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>ARCA Sicilia, Ragusa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>ARCA, Sicilia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zito</LastName><ForeName>Giovanni Battista</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>ARCA Campania, Pompei, (Na), Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol Cardiovasc Risk Prev</MedlineTA><NlmUniqueID>9918282077306676</NlmUniqueID><ISSNLinking>2772-4875</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Covid-19</Keyword><Keyword MajorTopicYN="N">Long Covid</Keyword><Keyword MajorTopicYN="N">Pericarditis</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors report no relationships that could be construed as a conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>19</Day><Hour>3</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38638196</ArticleId><ArticleId IdType="pmc">PMC11024661</ArticleId><ArticleId IdType="doi">10.1016/j.ijcrp.2024.200267</ArticleId><ArticleId IdType="pii">S2772-4875(24)00032-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Worldometer, March 18, 2023. https://www.worldometers.info/coronavirus/</Citation></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43(11):1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031. 14 March.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Medscape Medical News. Fauci introduces new acronym for long COVID (February 24,2021). https://www.medscape.com/viewarticle/946419. (Accessed 6 November 2022).</Citation></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline [NG188]. page 6; Published: 18 December 2020 Last updated: 25 January 2024 Nice website: www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>World Health Organization (WHO): Geneva, Switzerland. 2021. Living guidance for clinical management of COVID-19; 23 November 2021.https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2</Citation></Reference><Reference><Citation>Gy&#xf6;ngy&#xf6;si M., Alcaide P., Asselbergs F.W., et al. Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovasc. Res. 2023 Mar 31;119(2):336&#x2013;356. doi: 10.1093/cvr/cvac115. PMID: 35875883; PMCID: PMC9384470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac115</ArticleId><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="pubmed">35875883</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud Z., East L., Gleva M., Woodard P.K., Lavine K., Verma A.K. Cardiovascular symptom phenotypes of post-acute sequelae of SARS-CoV-2. Int. J. Cardiol. 2022 Nov 1;366:35&#x2013;41. doi: 10.1016/j.ijcard.2022.07.018. Epub 2022 Jul 13. PMID: 35842003; PMCID: PMC9278009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.07.018</ArticleId><ArticleId IdType="pmc">PMC9278009</ArticleId><ArticleId IdType="pubmed">35842003</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter D., Guasti L., Koehler F., et al. Late phase of COVID-19 pandemic in general cardiology. A position paper of the ESC council for cardiology practice. ESC Heart Fail. 2021 Oct;8(5):3483&#x2013;3494. doi: 10.1002/ehf2.13466. Epub 2021 Jun 25. PMID: 34170086; PMCID: PMC8427022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13466</ArticleId><ArticleId IdType="pmc">PMC8427022</ArticleId><ArticleId IdType="pubmed">34170086</ArticleId></ArticleIdList></Reference><Reference><Citation>Hira R., Baker J.R., Siddiqui T., et al. Canadian long COVID autonomic network (CanLoCAN). Objective hemodynamic cardiovascular autonomic abnormalities in post-acute sequelae of COVID-19. Can. J. Cardiol. 2022 doi: 10.1016/j.cjca.2022.12.002. Dec 9:S0828-282X(22)01091-1. Epub ahead of print. PMID: 36509178; PMCID: PMC9733966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2022.12.002</ArticleId><ArticleId IdType="pmc">PMC9733966</ArticleId><ArticleId IdType="pubmed">36509178</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S., Qin M., Shen B., et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in wuhan, China. JAMA Cardiol. 2020 Mar 25 doi: 10.1001/jamacardio.2020.0950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo A., Kasal D.A., Tura B.R., et al. Acute cardiac injury in patients with COVID-19. Am J Cardiovasc Dis. 2020;10(2):28&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7364273</ArticleId><ArticleId IdType="pubmed">32685261</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsch&#xf6;pe C., Ammirati E., Bozkurt B. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat. Rev. Cardiol. 2021;18:169&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7548534</ArticleId><ArticleId IdType="pubmed">33046850</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y., Giovini M., Leone M. Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review. Ann. Intensive Care. 2020;10:124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492788</ArticleId><ArticleId IdType="pubmed">32953201</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry C., Bayes H.K. Post-COVID-19 illness trajectory in community patients: mostly reassuring results. Eur. Heart J. 2022;43(11):1138&#x2013;1140. doi: 10.1093/eurheartj/ehac057. 14 March.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac057</ArticleId><ArticleId IdType="pmc">PMC8918382</ArticleId><ArticleId IdType="pubmed">35165717</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603. Aug 11. PMID: 32644129; PMCID: PMC7349096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulson N., Petek B.J., Drezner J.A., et al. SARS-CoV-2 cardiac involvement in young competitive athletes. Circulation. 2021;144:256&#x2013;266. doi: 10.1161/CIRCULATIONAHA.121.054824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.054824</ArticleId><ArticleId IdType="pmc">PMC8300154</ArticleId><ArticleId IdType="pubmed">33866822</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoncecchi V., Oliviero U., Savino K., et al. The ARCA post-COVID (assessing the rate of CArdiopathy in post-COVID patients) registry cardiologia. Ambulatoriale. 2021;3:86&#x2013;191. doi: 10.17473/1971-6818-2021-3-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.17473/1971-6818-2021-3-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28(3):583&#x2013;590. doi: 10.1038/s41591-022-01689-3. Mar. Epub 2022 Feb 7. PMID: 35132265; PMCID: PMC8938267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Guevarra C.C., Murray N., Cipriani D., et al. Cardiovascular involvement among collegiate athletes following COVID-19 infection. J Clin Transl Res. 2022 Jan 3;8(1):1&#x2013;5. PMID: 35097235; PMCID: PMC8791243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8791243</ArticleId><ArticleId IdType="pubmed">35097235</ArticleId></ArticleIdList></Reference><Reference><Citation>Starekova J., Bluemke D.A., Bradham W.S., et al. Evaluation for myocarditis in competitive student athletes recovering from coronavirus disease 2019 with cardiac magnetic resonance imaging. JAMA Cardiol. 2021 Aug 1;6(8):945&#x2013;950. doi: 10.1001/jamacardio.2020.7444. PMID: 33443537; PMCID: PMC7809616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.7444</ArticleId><ArticleId IdType="pmc">PMC7809616</ArticleId><ArticleId IdType="pubmed">33443537</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchian M.L., Motoc A., Lochy S., et al. Subclinical myocardial dysfunction in patients with persistent dyspnea one year after COVID-19. Diagnostics. 2021;12(1):57. doi: 10.3390/diagnostics12010057. Dec 28. PMID: 35054224; PMCID: PMC8775030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12010057</ArticleId><ArticleId IdType="pmc">PMC8775030</ArticleId><ArticleId IdType="pubmed">35054224</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sluijs K.M., Bakker E.A., et al. Long-term cardiovascular health status and physical functioning of nonhospitalized patients with COVID-19 compared with non-COVID-19 controls. Am. J. Physiol. Heart Circ. Physiol. 2023 Jan 1;324(1):H47&#x2013;H56. doi: 10.1152/ajpheart.00335.2022. Epub 2022 Dec 2. PMID: 36459448; PMCID: PMC9870581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00335.2022</ArticleId><ArticleId IdType="pmc">PMC9870581</ArticleId><ArticleId IdType="pubmed">36459448</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B. Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Med. Sci. Mon. Int. Med. J. Exp. Clin. Res. 2021;27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7924007</ArticleId><ArticleId IdType="pubmed">33633106</ArticleId></ArticleIdList></Reference><Reference><Citation>Honigsbaum M., Krishnan L. Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers. Lancet. 2020;396:1389&#x2013;1391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550169</ArticleId><ArticleId IdType="pubmed">33058777</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatr. 2021;8:416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J., Piroth L., Epaulard O., et al. COVID cohort study and investigators groups. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin. Microbiol. Infect. 2021 Jul;27(7) doi: 10.1016/j.cmi.2021.03.012. 1041.e1-1041.e4. Epub 2021 May 10. PMID: 34125067; PMCID: PMC8107834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.03.012</ArticleId><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., et al. Group A.R.C.S. 'Long-35 COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities 36 following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Heesakkers H., van der Hoeven J.G., Corsten S., et al. Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19. JAMA. 2022;327:559&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8787680</ArticleId><ArticleId IdType="pubmed">35072716</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>D. Ayoubkhani. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. Office for National Statistics https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023.</Citation></Reference><Reference><Citation>E.T. Cirulli, K.M. Schiabor Barrett, S.Riffle, et al. Long-term COVID-19 symptoms in a large unselected population. Preprint at bioRxiv 10.1101/2020.10.07.20208702 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein H., Asseo K., Karni N., et al. Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients. Clin. Microbiol. Infect. 2021 Feb 16;27(5):769&#x2013;774. doi: 10.1016/S2213-2600(21)00383-0. 10.1016/j.cmi.2021.02.008. Epub ahead of print. PMID: 33607252; PMCID: PMC7884919 Evans, R. A. et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir. Med.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC7884919</ArticleId><ArticleId IdType="pubmed">33607252</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Pinto M.D., Borelli J.L., et al. COVID symptoms, symptom clusters, and predictors for becoming a long-hauler looking for clarity in the haze of the pandemic. Clin. Nurs. Res. 2022 Nov;31(8):1390&#x2013;1398. doi: 10.1177/10547738221125632. Epub 2022 Sep 24. PMID: 36154716; PMCID: PMC9510954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10547738221125632</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Yomogida K., Zhu S., Rubino F., Figueroa W., Balanji N., Holman E. Post-acute sequelae of SARS-CoV-2 infection among adults aged &#x2265;18 Years - long beach, California, april 1-december 10, 2020. MMWR Morb. Mortal. Wkly. Rep. 2021;70(37):1274&#x2013;1277. doi: 10.15585/mmwr.mm7037a2. Sep. 17. Erratum in: MMWR Morb Mortal Wkly Rep. 2021 Oct 01;70(39):1390. PMID: 34529639; PMCID: PMC8445372.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7037a2</ArticleId><ArticleId IdType="pmc">PMC8445372</ArticleId><ArticleId IdType="pubmed">34529639</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G., Brokstad K.A., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M., Lewek J., Kapusta J., Banach M., Jankowski P., Bielecka-Dabrowa A. Predictors of long COVID in patients without comorbidities: data from the polish long-COVID cardiovascular (PoLoCOV-CVD) study. J. Clin. Med. 2022;11:4980. doi: 10.3390/jcm11174980.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11174980</ArticleId><ArticleId IdType="pmc">PMC9456773</ArticleId><ArticleId IdType="pubmed">36078910</ArticleId></ArticleIdList></Reference><Reference><Citation>Dini F.L., Baldini U., Byty&#xe7;i I., Pugliese N.R., Bajraktari G., Henein M.Y. Acute pericarditis as a major clinical manifestation of long COVID-19 syndrome. Int. J. Cardiol. 2023;374:129&#x2013;134. doi: 10.1016/j.ijcard.2022.12.019. Mar 1. Epub 2022 Dec 10. PMID: 36513284; PMCID: PMC9734068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.12.019</ArticleId><ArticleId IdType="pmc">PMC9734068</ArticleId><ArticleId IdType="pubmed">36513284</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen E.L., Go&#xdf;ling A., Adam G., et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg City Health Study COVID programme. Eur. Heart J. 2022;43(11):1124&#x2013;1137. doi: 10.1093/eurheartj/ehab914. Mar 14. PMID: 34999762; PMCID: PMC8755397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab914</ArticleId><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Parhizgar P., Yazdankhah N., Rzepka A.M., et al. Beyond acute COVID-19: a review of long-term cardiovascular outcomes. Can. J. Cardiol. 2023 doi: 10.1016/j.cjca.2023.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2023.01.031</ArticleId><ArticleId IdType="pmc">PMC9901229</ArticleId><ArticleId IdType="pubmed">36754119</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>